Benchmark Radar™
Star —

MetaboNet-Bench

Explore score history ↗

MetaboNet-Bench evaluates multimodal glucose forecasting in type 1 diabetes, using glucose, insulin, and carbohydrate data. It provides an extensible open-source evaluation framework for comparing forecasting algorithms.

Released
2026-06-17
Institutions
Stanford Medicine · Stanford University · New York Life Insurance Company (United States)
Evaluates
Biology & Drug Discovery, Multimodal
Openness
unknown
Importer
Claire Radar
Review status
unreviewed

MetaboNet-Bench paper

No reported scores are on record for this benchmark yet.

Which sources cite MetaboNet-Bench?

Related Biology & Drug Discovery, Multimodal benchmarks